The Status of Platinum Anticancer Drugs in the Clinic and in Clinical Trials
EURON WORKSHOP Drugs and the Brain: from Laboratory to Clinic … · 2019-06-14 · EURON WORKSHOP...
7
Oct.1 - 5 2019 University of Crete PROGRAMME EURON WORKSHOP Drugs and the Brain: from Laboratory to Clinic Organization European Graduate School of Neuroscience (EURON) in collaboration with the University of Crete, Heraklion, Greece
Transcript of EURON WORKSHOP Drugs and the Brain: from Laboratory to Clinic … · 2019-06-14 · EURON WORKSHOP...
Oct.1 - 52019University of Crete
PROGRAMME
EURON WORKSHOP
Drugs and the Brain: from Laboratory to Clinic
OrganizationEuropean Graduate School of Neuroscience (EURON)in collaboration with the University of Crete, Heraklion, Greece
INTRODUCTIONIn this EURON workshop different topics in relation to Psychopharmacology will be presented.The topics for this event are:• NEURODEGENERATION• NEURODEVELOPMENT• BRAIN‐GUT AXIS• ILLICIT DRUGS• MOOD
The aim of this workshop is to give an up-to-date overview of the latest developments in these different research fields. Students will get a better understanding how drugs work in the brain and how drugs can be developed for treatment in various brain diseases. The different thematic topics will be accompanied by interactive workshops. In these workshops small groups will discuss a specific topic that relates to the theme on a specific day. This will stimulate active participation in discussions, and is further encouraged by educationally well‐trained experts, coming from academia and industry. Participants also have the opportunity to present their own research in poster and elevator pitch sessions. One day will be organized in collaboration with the Hellenic Society for Neuroscience (HSfN). Next to the scientific programme there will be a social programme.
PRELIMINARY PROGRAMMEVenue: School of Medicine, University of Crete TUESDAY OCT 1ST - NEURODEGENERATIONLocation: University of Crete Medical School• 09.00 - Registration• 10.00 - Opening, Introduction and General information
Prof. Arjan Blokland, Dr. Gunter Kenis and Prof. Kiki Thermos• Opening Lecture: The future of depression research: the search for a new
generation of antidepressants. Prof. Brian Leonard (National University of Galway, Ireland)
• Elevator pitches participants (ca. 10 participants)• Lunch• Three expert lectures: − Cognitive Aging: insights from functional and molecular neuroimaging Prof. Bernard Hanseeuw (UCLouvain, Brussels, Belgium) − Alzheimer’s Disease and epigenetics Dr. Gunter Kenis (Maastricht University, The Netherlands) − Novel treatments for cognition in Alzheimer’s Disease Prof. Jos Prickaerts (Maastricht University, The Netherlands)• Elevator pitches of participants (ca. 10 participants)• Joint dinner
PROGRAMME
WEDNESDAY OCT 2ND - NEURODEVELOPMENTLocation: University of Crete Medical School• Morning: three expert lectures − mTOR in developmental disorders Prof. Martien Kas (Groningen University, The Netherlands) − Vasopressin 1a receptor antagonism as a treatment for autism Dr. Barbara Biemans (Roche, Basel, Switzerland) − Early SSRI exposure and neurodevelopmental disorders Dr. Jocelien Olivier (Groningen University, The Netherlands) − If pregnant woman get depressed they should use antidepressants • Afternoon: interactive sessions − Workshop 1 Title “to be announced” Moderator Martien Kas − Workshop 2 Title “to be announced” Moderator Dr. Jocelyn Olivier − Workshop 3 Animal models of psychiatric disorders are of minimal relevance
for the development of novel psychotropic drugs and have contributed to the lack of significant progress in the therapeutic advance in recent years.
Moderator Prof. Arjan Blokland• Plenary presentations of the outcome of the workshops and discussion Moderator Prof. Brian Leonard• Social activity: sight seeing
THURSDAY OCT 3RD - ILLICIT DRUGSLocation: University of Crete Medical School• Three expert lectures − MDMA: neurotoxin of promising therapeutic aid? Dr. Kim Kuypers (Maastricht University, The Netherlands) − Acute and long‐term effects of the ‘new kids on the block’ (novel psycho‐active
substances) on physiological and behavioral parameters/receptor profiles Dr. Tomas Palenicek (NIMH, Czech Republic) − Acute and long‐term effects of psychedelics and their therapeutic potential Dr. Jordi Riba (University of Barcelona, Spain)• Elevator pitches of participants (ca. 10 participants)• Lunch• Afternoon: interactive sessions − Workshop 1 Are psychedelics good or bad? Moderator Dr. Kim Kuypers − Workshop 2 Neurotransmitters have no functions. Moderator Prof. Arjan Blokland − Workshop 3 Title: to be announced. Moderator Tomas Palenicek• Plenary presentations of the outcome of the workshops and discussion Moderator Dr. Gunter Kenis• Joint dinner with music
PROGRAMME
FRIDAY OCT 4TH - BRAIN‐GUT AXIS AND MOODLocation: Institute of Molecular Biology and Biotechnology (IMBB) - integrated in Hellenic Society for Neuroscience Meeting• Morning: three expert lectures − Brain-Gut in Alzheimer’s Disease Prof. Dietmar Fuchs (Innsbruck University, Austria) − The Gut Microbiome, Brain Function and Behaviour: Moving the Goalposts
in Psychiatry? Dr. Gerard Clarke (University of Cork, Ireland) − Food and brain development Dr. Nora Schneider (Nestlé, Lasusanne, Switserland)• Poster presentations of workshop participants on the HSfN Meeting
SATURDAY OCT 5TH - CLINICAL DEVELOPMENT OF DRUGSLocation: University of Crete Medical School• Morning: three expert lectures − Drug development in pain Dr. John Bothmer (Grünenthal GmbH, Aachen, Germany) − CNS drug development: Alzheimer’s disease Prof. Wim Riedel (Maastricht University, The Netherlands) − Mechanism‐based approach to treat disease symptoms Prof. Harald Schmidt (Maastricht University, The Netherlands)• Lunch• Afternoon: interactive sessions − Workshop 1 There are no neurological diseases Moderator Prof. Harald Schmidt (Maastricht University, The Netherlands) − Workshop 2 There is no such thing as an inverted U‐shape dose response
relationship Moderator Prof. Wim Riedel (Maastricht University, The Netherlands) − Workshop 3 Pain and addiction cannot be dissociated with drug treatment Moderator Dr. John Bothmer (Grünenthal GmbH, Aachen, Germany)• Plenary presentations of the outcome of the workshops and discussion Moderator Prof. Arjan Blokland (Maastricht University, The Netherlands)• Evaluation workshop & Concluding remarks• Closure 15.30
PROGRAMME
ORGANIZATION:European Graduate School of Neuroscience (EURON), School for Mental Health and Neuroscience & Dept. of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, NL in collaboration with the Graduate Program of Neuroscience, University of Crete, Heraklion, Greece, and in conjunction with the Hellenic Society for Neuroscience.
ORGANIZERS:Maastricht University: Prof. Arjan Blokland, Dr. Gunter Kenis, Prof. Jos Prickaerts, Dr. Nicole Senden, Peggy Bisschoff, Damaris Kentgens.University of Crete: Prof. Kyriaki Thermos, Dr. Kyriaki Sidiropoulou.
REGISTRATION:The workshop is open for PhD students, junior post‐doctoral researchers (in excep-tional cases also for master students doing an internship in a relevant research field) with a maximum of 50 participants.The registration starts on March 1st, 2019.Early bird registration: March 1- July 1 / Late registration: July 1- August 1.Abstract submission deadline: September 1.
FEE*: Early bird: Late registration:Euron Members: E350 Euron Members: E400Non-Euron: E450 Non-Euron: E500Industry: E650 Industry: E700
* The registration fee includes: lunches, two dinners, social event, accommodation (sept. 30 - oct. 4) based on
sharing double rooms (single room: E50 extra additional fee).
This workshop qualifies for 2 European credits.Participants will get a certificate of attendance listing the credits.
STIPENDS: This workshop has been awarded by the FENS and IBRO PERC programme. The FENS organization will offer stipends to cover the costs related to the programme. The stipend is E750 each for 4 students (master and/or PhD students; European or non-European) not residing in the Netherlands or Greece.Application deadline: July 1, 2019. Link to the application form for the FENS and IBRO-PERC stipend.
MORE INFORMATION: http://www.euronschool.eu/[email protected]
GENER
AL INFO
RMATION
TEACHING CONTENT:Lectures by experts in the field.Discussion groups on a specific statement, moderated by the experts in the field. Afterwards, each group will give a presentation on their findings during a plenary session.Poster presentations: participants will be encouraged to submit an abstract of their research and present a poster. Elevator pitches: 5 minutes short presentations by participants.
FACULTY LIST / ORGANIZERSDr. Barbara Biemans, Laboratory Head Developmental & Behavioral Neuroscience, F. Hoffmann‐La‐Roche, Basel, Switzerland | [email protected]
Prof. Arjan Blokland, Prof. Section Psychopharmacology,Neuropsychology & Psychopharmacology Departments, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands | [email protected]
Dr. John Bothmer, Innovation Unit Pain, Grünenthal GmbH, Aachen, Germany | [email protected]
Dr. Gerard Clark, Dept of Psychiatry, University College Cork, Ireland | [email protected]
Dietmar Fuchs, Division of Biological Chemistry, Biocentre, Medical University of Innsbruck, Austria |[email protected]
Prof. Bernard Hanseeuw, Institute of Neuroscience (IoNs), UC Louvain, Brussels, Belgium | [email protected]
Prof. Martien Kas, Prof. of Behavioral Neuroscience, Facultyof Science and Engineering, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands | [email protected]
Dr. Gunter Kenis, Director EURON, School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands | [email protected]
Dr. Kim Kuypers, Ass. Prof. Section Psychopharmacology, Dept. Neuropsychology & Psychophar-macology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands | [email protected]
Prof. Brian Leonard, Em. Prof. Pharmacology, National University of Galway, Ireland | [email protected] Dr. Tomas Palenicek, National Institute of Mental Health, Czech Republic | [email protected]
Dr. Jocelien Olivier, Faculty of Science and Engineering, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands | [email protected]
Dr. Tomas Palenicek, National Institute of Mental Health, Czech Republic | [email protected]
Prof. Jos Prickaerts, Prof. Experimental Neuropsychopharmacology, Dept. Psychiatry & Neuropsy-chology, School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands | [email protected]
Dr. Jordi Riba, Sant‐Pau Institute of Biomedical Research, Research Group Human Neuropsycho-pharmacology, University of Barcelona, Spain | [email protected]
GENER
AL INFO
RMATION
Prof. Wim Riedel, Prof. Section Psychopharmacology,Neuropsychology & Psychopharmacology Departments, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands | [email protected]
Prof. Harald Schmidt, Prof. of Pharmacology, Dept. of Pharmacology and Personalised Medicine, School for Cardiovascular Diseases, Fac. Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands | [email protected]
Dr. Nora Schneider, Nestlé Research, Lausanne, Switzerland | [email protected]
Dr. Nicole Senden, Programme Coordinator EURON, Maastricht University, Maastricht, The Netherlands | [email protected]
Dr. Kyriaki Sidiropoulou, Dept of Biology, University of Crete, Heraklion | [email protected]
Prof. Kyriaki (Kiki) Thermos, Prof. of Pharmacology, School of Medicine, University of Crete, Heraklion, Crete, Greece | [email protected]
GENER
AL INFO
RMATION
